Nutritional and immunologic scoring systems to predict complications and outcomes after anti-B-cell maturation antigen chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma
{{output}}
Background aims: Chimeric antigen receptor (CAR) T-cell therapy has significant benefits in the treatment of relapsed/refractory multiple myeloma (R/R MM). Despite the established correlation between nutritional status and the un... ...
